Tetra Bio-Pharma
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $24,295,128.

Profit Margin

Tetra Bio-Pharma Inc. (TSX:TBP.TO): Profit margin
2012 0 -554.90K
2013 0 -2.10M
2014 0 -414.13K
2015 0 -594.78K
2016 0 -944.25K
2017 0 -6.22M
2018 112.32K -7.57M -6741.95%
2019 0 -15.66M
2020 0 -26.89M
2021 0 -53.41M

TBP.TO Income Statement (2012 – 2021)

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Revenue
Revenue
000112.32K000000
Cost of revenue
00067.59K000000
Gross profit
00044.72K000000
Operating exp.
Research and development
11.93M11.65M6.19M5.96M2.06M263.54K0000
Selling and marketing
000603.44K0106.39K109.70K40.09K12.08K115.75K
Total operating expenses
24.29M20.46M13.86M11.62M6.39M982.71K473.82K310.23K156.20K401.71K
Operating income
-24.84M-19.94M-13.38M-11.58M-6.39M-982.71K-473.82K-310.23K-156.20K-401.71K
Other income (expenses), net
-27.33M-1.21M-860.16K3.73M-298.56K-14.25K-120.96K-103.89K-1.95M-225.64K
Income before tax
-52.17M-21.15M-14.24M-7.85M-6.69M-996.96K-594.78K-414.13K-2.10M-627.35K
Income tax expense
1.24M5.74M1.42M3.73M-298.56K-52.70K000-72.44K
Net income
-53.41M-26.89M-15.66M-7.57M-6.22M-944.25K-594.78K-414.13K-2.10M-554.90K
Earnings per share
Basic EPS
-0.12-0.1-0.08-0.05-0.05-0.01-0.01-0.01-0.08-0.02
Diluted EPS
-0.12-0.1-0.08-0.05-0.05-0.01-0.01-0.01-0.08-0.02
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source